Inscription Capital LLC Sells 33,947 Shares of Colgate-Palmolive Company $CL

Inscription Capital LLC reduced its stake in Colgate-Palmolive Company (NYSE:CL) by 69.5% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 14,903 shares of the company’s stock after selling 33,947 shares during the quarter. Inscription Capital LLC’s holdings in Colgate-Palmolive were worth $1,271,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Corient Private Wealth LP lifted its stake in shares of Colgate-Palmolive by 29.0% in the second quarter. Corient Private Wealth LP now owns 639,604 shares of the company’s stock worth $58,639,000 after buying an additional 143,812 shares in the last quarter. Bank of America Corp DE bought a new position in Colgate-Palmolive in the 2nd quarter valued at approximately $567,483,000. Brandywine Financial Group boosted its stake in Colgate-Palmolive by 35,612.3% during the 1st quarter. Brandywine Financial Group now owns 72,853 shares of the company’s stock valued at $6,209,000 after purchasing an additional 72,649 shares during the last quarter. SEB Asset Management AB bought a new stake in shares of Colgate-Palmolive in the 1st quarter worth $91,149,000. Finally, Robinhood Asset Management LLC purchased a new position in shares of Colgate-Palmolive in the second quarter worth $11,554,000. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Analyst Upgrades and Downgrades

CL has been the topic of several recent analyst reports. Bank of America increased their price objective on Colgate-Palmolive from $100.00 to $105.00 and gave the company a “buy” rating in a research report on Monday. Wells Fargo & Company raised their price target on shares of Colgate-Palmolive from $90.00 to $95.00 and gave the company an “equal weight” rating in a report on Monday. TD Cowen boosted their price objective on shares of Colgate-Palmolive from $90.00 to $97.00 and gave the company a “hold” rating in a report on Monday. BNP Paribas Exane reissued an “outperform” rating and set a $108.00 price objective (up from $97.00) on shares of Colgate-Palmolive in a report on Monday. Finally, Royal Bank Of Canada increased their price objective on shares of Colgate-Palmolive from $104.00 to $105.00 and gave the company an “outperform” rating in a research report on Monday. Thirteen analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $101.22.

Colgate-Palmolive Trading Down 0.1%

Shares of NYSE:CL opened at $98.68 on Friday. Colgate-Palmolive Company has a 52-week low of $75.96 and a 52-week high of $101.18. The stock has a market capitalization of $78.44 billion, a price-to-earnings ratio of 25.45, a PEG ratio of 4.48 and a beta of 0.31. The company has a debt-to-equity ratio of 11.23, a quick ratio of 0.30 and a current ratio of 0.96. The stock’s 50-day simple moving average is $90.01 and its two-hundred day simple moving average is $89.92.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, October 30th. The company reported $0.97 earnings per share for the quarter, topping the consensus estimate of $0.93 by $0.04. The firm had revenue of $5.37 billion for the quarter, compared to analysts’ expectations of $5.34 billion. Colgate-Palmolive had a net margin of 9.65% and a return on equity of 607.88%. The business’s quarterly revenue was up 4.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.91 EPS. Analysts expect that Colgate-Palmolive Company will post 3.91 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Tuesday, October 20th will be given a $0.53 dividend. The ex-dividend date is Tuesday, October 20th. This represents a $2.12 annualized dividend and a yield of 2.1%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 83.14%.

More Colgate-Palmolive News

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: Several analysts raised their price targets, and BNP Paribas Exane reaffirmed its Outperform rating. The reports include updates from Read More., Read More., Read More., and Read More.. A separate report highlighted Morgan Stanley’s expectation for strong potential appreciation. Morgan Stanley report
• Positive Sentiment: Colgate-Palmolive’s defensive consumer-staples profile and dividend history may appeal to investors seeking reliable businesses amid political uncertainty. Its recent quarterly results also beat analyst estimates, as noted in the broader discussion of dividend stocks’ resilience. Dividend Kings article
• Neutral Sentiment: Analyst views are not uniformly bullish: Barclays maintained a Hold rating even as other coverage reported a target increase. This points to some optimism about upside but continued caution on valuation or near-term prospects. Barclays rating
• Negative Sentiment: Rising oil prices and cautious U.S. consumers are pressuring consumer-goods companies’ margins, a potential headwind for Colgate-Palmolive if costs rise faster than it can pass them through. Dividend-stock comparison
• Negative Sentiment: Colgate’s valuation may also weigh on the shares: a comparison with Hershey noted that Hershey trades at a lower forward P/E despite revenue growth, making CL look less attractive to valuation-focused investors. Colgate and Hershey comparison

Insiders Place Their Bets

In other news, COO Panagiotis Tsourapas sold 10,000 shares of Colgate-Palmolive stock in a transaction on Monday, August 24th. The shares were sold at an average price of $92.05, for a total transaction of $920,500.00. Following the transaction, the chief operating officer owned 64,901 shares in the company, valued at $5,974,137.05. This trade represents a 13.35% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 0.43% of the company’s stock.

Colgate-Palmolive Profile

Colgate-Palmolive Company (NYSE: CL) is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwash, liquid hand soap, body wash, deodorants, household cleaning products and pet food and treats.

The company markets well-known brands such as Colgate, Palmolive, elmex, meridol, Softsoap, Irish Spring, Ajax, Protex and Hill’s Science Diet. Colgate-Palmolive also provides veterinary and nutritional products through Hill’s Pet Nutrition, which serves pet owners and animal health professionals.

Founded in 1806 by William Colgate, the company developed from a soap and candle business into a diversified consumer goods manufacturer.